Transitions

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

FDA warns of dental problems associated with certain buprenorphine...

Tuesday, January 18, 2022 0 27426

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.

New HIV PrEP guidelines call for clinicians to talk with patients about...

Monday, January 10, 2022 0 35313

CDC now advises all clinicians to talk to their patients who are sexually active, including adolescents, about HIV preexposure prophylaxis (PrEP) at least once and to prescribe the prevention medication to anyone who requests them.

Study links statins with more aggressive diabetes progression

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new...

FDA puts clozapine REMS requirements on temporary hold

FDA said it is temporarily halting its risk evaluation and mitigation strategy (REMS) program for clozapine, a treatment for schizophrenia.

ISMP warns about confusion with co-packaging, labeling on monoclonal...

The Institute for Safe Medication Practices (ISMP) is alerting health care providers about potential confusion over new alternative packaging for...

Uptake of newer diabetes products dominate trends in U.S. adults with...

New research published in JAMA Network Open finds that insulin glargine and other insulin analogs are the most-used forms of insulin in the United...

NIH researchers identify potential new antiviral drug for COVID-19

An experimental drug, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol), may be a promising oral antiviral treatment for COVID-19,...

Can atorvastatin with sodium valproate reduce migraine?

Adding atorvastatin to the prophylactic regimen for patients with migraine with aura may help reduce the number of acute attacks and...

Tuesday, May 11, 2021

Hypertension seems to worsen with these common prescription medications

Study findings reveal that adults in the United States diagnosed with hypertension often take other medications that contribute to high blood pressure.

Transitions Magazine

FDA warns of dental problems associated with certain buprenorphine...

New HIV PrEP guidelines call for clinicians to talk with patients about...

Study links statins with more aggressive diabetes progression

FDA puts clozapine REMS requirements on temporary hold

ISMP warns about confusion with co-packaging, labeling on monoclonal...

Uptake of newer diabetes products dominate trends in U.S. adults with...

NIH researchers identify potential new antiviral drug for COVID-19

Can atorvastatin with sodium valproate reduce migraine?

Hypertension seems to worsen with these common prescription medications